US Patent Issued to Wyvern Pharmaceuticals on June 24 for "Compositions for regulating production of an antibody like protein and ribonucleic acid" (Canadian Inventor)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,452, issued on June 24, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada).

"Compositions for regulating production of an antibody like protein and ribonucleic acid" was invented by Bradley G. Thompson (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Some embodiments of the present disclosure relate to one or more compositions for regulating the production of an antibody-like protein (ALP) and ribonucleic acid (RNA). In particular, the present disclosure relates to compositions for regulating the gene expression and, therefore, the production, of an ALP and an interfering RNA (iRNA), which may suppress viral infections. In ...